Table 5 The correlation between the three Circulating DNA methylations and overall survival.

From: Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer

Survival

SEPTIN9

SDC2

BCAT1

Composite score (P)

Yes (40)

35.0 ± 1.7

39.9 ± 2.4

35.9 ± 2.3

5.6 ± 1.0

No (22)

34.1 ± 2.8

37.0 ± 4.1

34.9 ± 2.8

6.4 ± 1.7

P value

–

**

–

–

Overall survival

 ≤ 6 months (4)

31.6 ± 0.8

31.1 ± 1.1

31.9 ± 1.5

8.4 ± 0.6

Ā > 6 months (58)

34.6 ± 2.8

38.4 ± 3.1

35.6 ± 2.6

5.9 ± 1.6

Ā P value

**

***

**

***

  ≤ 12 months (8)

33.3 ± 2.6

34.2 ± 4.3

33.6 ± 2.7

7.2 ± 1.8

> 12 months (54)

34.5 ± 2.9

38.7 ± 3.0

35.6 ± 2.8

5.9 ± 1.6

Ā P value

–

***

**

**

Median survival time

 ≤ 46.5 months (44)

34.8 ± 2.6

39.0 ± 3.9

35.6 ± 2.8

5.8 ± 1.6

Ā > 46.5 months (18)

34.3 ± 0.6

38.6 ± 1.7

35.3 ± 1.6

6.0 ± 0.5

Ā P value

–

–

–

–

  1. Overall survival was analyzed by independent samples t-test (p value) with 6-or 12-month survival time as the endpoint criteria. The median survival time of 46.5 months was obtained by Kaplan-Meier survival analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. These data were collected by Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital from January 2019 to May 2023.